Senescent cell accumulation has been observed in age-associated diseases including
cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence …

The management and treatment of disease are achieved via the use of pharmacologically
active substances or drugs. Drugs do not, however, have an intrinsic ability to be effective; …

Heterotopic ossification (HO) represents an unwanted ossific wound healing response to the
soft tissue injury which caused catastrophic limb dysfunction. Recent studies established the …

Aging is a major risk factor for cardiovascular diseases (CVDs) and accumulating evidence
indicates that biological aging has a significant effect on the onset and progression of CVDs …

The prevalence of cardiovascular diseases markedly rises with age. Cellular senescence, a
hallmark of aging, is characterized by irreversible cell cycle arrest and the manifestation of a …

To investigate the instent restenosis rate of sirolimus-coated stents in percutaneous
coronary intervention (PCI) and risk factors for in-stent restenosis, patients with unstable …

Although the incidence of restenosis and stent thrombosis has substantially declined during
the last decades, they still constitute the two major causes of stent failure. These …

Abstract Poly (L-lactic acid)(PLLA) drug-coated stents are increasingly recognized for
treating arterial diseases, owing to their biocompatibility, mechanical strength, and drug …

In the present study, we evaluated the association of the BAT1, NFKBIL, LTA, and CASP1
single nucleotide polymorphisms and the gene–gene interactions with risk of developing …